Brachytherapy for Soft Tissue Sarcoma: Maintaining Local Control While Minimizing Complications
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.27999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Julien Montreuil und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Brachytherapy, Sarcoma, Postoperative Complications, Soft Tissue Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aims to assess the clinical and oncologic outcomes of high‐dose brachytherapy (BRT) versus both preoperative and postoperative external beam radiation therapy (EBRT) in the setting of high‐grade soft tissue sarcoma.
Methods
This is a retrospective cohort study of 144 patients treated surgically for soft tissue sarcoma at the same institution from 2010 to 2021. Patients treated for a soft tissue sarcoma with surgery and radiation therapy in the form of BRT, Neoadjuvant EBRT (Neo‐EBRT) or adjuvant EBRT (AD‐EBRT) were included.
Results
56 patients were treated with BRT, 42 with Neo‐EBRT, and 46 with AD‐EBRT. There was a greater incidence of grouped wound complications in Neo‐EBRT with 50% compared to both BRT with 25% and AD‐EBRT with 28.3% ( p = 0.02). Univariate and multivariate analysis showed that there was an increased risk of wound complications with Neo‐EBRT when compared to brachytherapy ( p = 0.03 and p = 0.007, respectively). Univariate and multivariate analysis showed that there was no difference in risk of LR between treatment groups ( p = 0.28).
Conclusion
Brachytherapy is a valuable treatment modality that offers clinical and logistical advantages when compared to the conventional Neo‐EBRT in soft tissue sarcomas. Brachytherapy offers a lower risk of wound complications and a comparable local control. This manuscript presents decision‐making strategies for determining the appropriate radiation modality for specific circumstances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, University of Miami Miller School of Medicine, Miami, Florida, USA.
- University of Miami Miller School of Medicine, Miami, Florida, USA.
- Cancer HealthCare Associates, Miami, Florida, USA.
- Department of Radiation Oncology, University of Miami School of Medicine, Miami, Florida, USA.
Zitieren
APA
Montreuil, J., Kholodovsky, E., Markowitz, M., Torralbas Fitz, S., Campano, D., Geiger, E., Hornicek, F., Crawford, B., Keisch, M., & Temple, H. T. (2025). Brachytherapy for Soft Tissue Sarcoma: Maintaining Local Control While Minimizing Complications. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27999
Vancouver
Montreuil J, Kholodovsky E, Markowitz M, Torralbas Fitz S, Campano D, Geiger E, et al. Brachytherapy for Soft Tissue Sarcoma: Maintaining Local Control While Minimizing Complications. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27999
BibTeX
@article{Montreuil2025,
author = {Montreuil, Julien and Kholodovsky, Eric and Markowitz, Moses and Torralbas Fitz, Sergio and Campano, Dominic and Geiger, Erik and Hornicek, Francis and Crawford, Brooke and Keisch, Martin and Temple, H Thomas},
title = {Brachytherapy for Soft Tissue Sarcoma: Maintaining Local Control While Minimizing Complications},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.27999}
}
EUVIMED